NYSE: EBS - Emergent BioSolutions Inc.

Yield per half year: +553.26%
Sector: Healthcare

Current price: 12.02 $
Average price: 10.95 $

Price based on EPS: 10.74 $ -10.66%
2.5/10

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 10.74 $
Current price = 12.02 $ (difference = -10.66%)


Data

Discounted Cash Flow (Based on EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 0.1743 $
Current price = 12.02 $ (difference = -98.55%)


Data

Discounted Cash Flow (Based on FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 1.1776 $
Current price = 12.02 $ (difference = -90.2%)


Data

Оплатите подписку

Больше функциональности и данных для анализа компаний и портфеля доступно по подписке